Advertisements


Bristol-Myers Squibb Q4 Earnings Preview

Bristol-Myers Squibb (NYSE: BMY) releases its next round of earnings this Thursday, Jan. 24. Here's Benzinga's essential guide to Bristol-Myers Squibb's Q4 earnings report. read more.....»»

Category: blogSource: benzingaJan 23rd, 2019

Q2 Earnings Preview For Bristol-Myers Squibb

On Thursday, Bristol-Myers Squibb (NYSE: BMY) will release its latest earnings report. Decipher the announcement with Benzinga's help. Earnings and Revenue Analysts expect Bristol-Myers Squibb earning.....»»

Category: earningsSource: benzingaJul 25th, 2018

Bristol-Myers Squibb Q4 Earnings Preview

Bristol-Myers Squibb (NYSE: BMY) releases its next round of earnings this Thursday, Jan. 24. Here's Benzinga's essential guide to Bristol-Myers Squibb's Q4 earnings report. Earnings and Revenue Wall S.....»»

Category: earningsSource: benzingaJan 23rd, 2019

Bristol-Myers Squibb Q4 Earnings Preview

Bristol-Myers Squibb (NYSE: BMY) releases its next round of earnings this Thursday, Jan. 24. Here's Benzinga's essential guide to Bristol-Myers Squibb's Q4 earnings report. read more.....»»

Category: blogSource: benzingaJan 23rd, 2019

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off

Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back to the across-t.....»»

Category: dealsSource: nytMay 16th, 2021

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off

Biotech stocks had a volatile ride in the week .....»»

Category: blogSource: benzingaMay 15th, 2021

Bristol-Myers Squibb"s stock gains 2% after adjusted earnings beat

Shares of Bristol-Myers Squibb gained 2.6% in premarket trading on Thursday after the drugmaker posted stronger-than-ex.....»»

Category: topSource: marketwatchMay 7th, 2020

Benzinga Pro"s Top 5 Stocks To Watch For Mon., May 4, 2020: DIS, BMY, PTON, QTNT, TBIO

Today's 5 Stock Ideas:  Disney (DIS) - An earnings play. Will report quarterly results after the close on Tuesday, May 5, 2020.  Bristol Myers Squibb (BMY) - A play on upcoming data related to read more.....»»

Category: blogSource: benzingaMay 4th, 2020

Bristol-Myers Squibb Smashes Earnings Predictions Following Celgene Acquisition

2019 marked a pivotal turning point for the pharmaceutical giantRelated Stocks: BMY,.....»»

Category: blogSource: gurufocusFeb 6th, 2020

Bristol-Myers Squibb reports 33% jump in Q4 revenue, Opdivo sales fall 2%

Shares of Bristol-Myers Squibb were up 2% in premarket trading on Thursday after the company beat earnings estimates for the fourth quarter of 2019. The company had a net loss of $1.1 billion, or 44 cents per share, in the fourth quarter of 2019, a.....»»

Category: topSource: marketwatchFeb 6th, 2020

Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q3 2019 Results - Earnings Call Transcript

Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q3 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaOct 31st, 2019

Bristol-Myers Squibb Posts Q3 Earnings Beat, Raises Full-Year Guidance

Bristol-Myers Squibb (NYSE: BMY) reported third-quarter earnings of $1.17 per share Thursday, beating the analyst consensus estimate of $1.07.  The company reported quarterly sales of $6.007 billion.....»»

Category: earningsSource: benzingaOct 31st, 2019

A Peek Into The Markets: US Stock Futures Trade Lower; European Markets Decline

Pre-open movers U.S. stock futures traded lower in early pre-market trade, ahead of earnings from Berkshire Hathaway Inc. (NYSE: BRK-A) and Bristol-Myers Squibb C.....»»

Category: earningsSource: benzingaOct 31st, 2019

Earnings Scheduled For October 31, 2019

Companies Reporting Before The Bell Bristol-Myers Squibb Company (NYSE: BMY) is expected to report quarterly earnings at $1.07 per share on revenue of $5.90 billion. read more.....»»

Category: blogSource: benzingaOct 31st, 2019

Bristol-Myers tops earnings estimates but lowers guidance

Bristol-Myers Squibb Co. shares rose 0.9% after the company beat earnings estimates but lowered its full-year per-share earnings guidance. The New York-based drug company said it had net income of $1.353 billion,.....»»

Category: topSource: marketwatchOct 31st, 2019

Fly Intel: What to watch in Bristol-Myers Squibb earnings report

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 30th, 2019

The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate

Biotech stocks moved mostly sideways during the week, although there was a flurry of activity in the space. Earnings from the sector began to trickle in, with Bristol-Myers Squibb Co (NYSE: BMY) reporting forecast-beating earnings. read more.....»»

Category: blogSource: benzingaJul 27th, 2019

Earnings Scheduled For July 25, 2019

Companies Reporting Before The Bell Comcast Corporation (NASDAQ: CMCSA) is estimated to report quarterly earnings at $0.75 per share on revenue of $27.08 billion. Bristol-Myers Squibb Company (NYSE: BMY) is expected to report quarterly earnings at .....»»

Category: earningsSource: benzingaJul 25th, 2019

Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q1 2019 Results - Earnings Call Transcript

Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q1 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaApr 25th, 2019

Bristol-Myers profit slightly tops Wall Street view on blood thinner sales

U.S drugmaker Bristol-Myers Squibb Co, which is set to buy biotechnology company Celgene Corp for $74 billion, posted slightly better-than-expected first-quarter earnings on Thursday on strong sales of its blockbuster blood thinner Eliquis......»»

Category: topSource: reutersApr 25th, 2019

Bristol-Myers Squibb (BMY) Q1 Earnings and Revenues Top Estimates

Bristol-Myers (BMY) delivered earnings and revenue surprises of 0.92% and 2.09%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Want the latest recommendations from Zacks Inve.....»»

Category: worldSource: nytApr 25th, 2019